An atypical presentation of ataxia telangiectasia in a school-aged boy secondary to an intronic mutation

Publication: LymphoSign Journal
4 May 2020

Abstract

Background: Ataxia telangiectasia typically presents in early pre-school years with progressive cerebellar ataxia and oculocutaneous telangiectasias. Referral to Immunology is often made after diagnosis has been established, as patients are prone to both humoral and cellular immune abnormalities.
Case presentation: We herein report a 10-year old boy, previously undiagnosed, who presented with recurrent pneumonias. On history, frequent falls and speech difficulty were reported, with no telangiectasias on exam. Screening with alpha-fetoprotein was abnormal, followed by ATM gene sequencing, showing a homozygous intronic mutation. Over the next 3 years the patient deteriorated neurologically, and developed appreciable telangiectasias.
Conclusion: A review of the literature demonstrates that intronic/splicing mutations may result in atypical ataxia telangiectasia phenotypes and delayed presentations. We advise immunologists to have a high index of suspicion for ataxia telangiectasia when assessing a patient with immunodeficiency and neurologic regression, regardless of age, and even in the absence of telangiectasias.
Statement of novelty: We present a case of phenotypically atypical (“leaky”) ataxia telangiectasia resulting from a novel homozygous splice-site mutation in the ATM gene. Given high reported prevalence of intronic and splice-site mutations in ATM, we recommend full gene sequencing in patients suspected to have ataxia telangiectasia, especially in those with late onset or unusual manifestations.

Formats available

You can view the full content in the following formats:

REFERENCES

Cavalieri S., Pozzi E., Gatti R.A., and Brusco A. 2013. Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO). Eur. J. Hum. Genet. 21(7): 774–778.
Coutinho G., Xie J., Du L., Brusco A., Krainer A.R., and Gatti R.A. 2005. Functional significance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a. Hum. Mutat. 25(2): 118–124.
Kim H.S., Choi S.I., Min H.L., Kim M.A., and Kim W.H. 2013. Mutation at intronic repeats of the ataxia-telangiectasia mutated (ATM) gene and ATM protein loss in primary gastric cancer with microsatellite instability. PLoS ONE, 8(12): e82769.
Platzer M., Rotman G., Bauer D., Uziel T., Savitsky K., Bar-Shira A., Gilad S., Shiloh Y., and Rosenthal A. 1997. Ataxia-telangiectasia locus: Sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res. 7(6): 592–605.
Teive H.A., Moro A., Moscovich M., Arruda W.O., Munhoz R.P., Raskin S., and Ashizawa T. 2015. Ataxia-telangiectasia—A historical review and a proposal for a new designation: ATM syndrome. J. Neurol. Sci. 355(1–2): 3–6.
Teraoka S.N., Telatar M., Becker-Catania S., Liang T., Önengüt S., Tolun A., Chessa L., Sanal Ö., Bernatowska E., Gatti R.A., and Concannon P. 1999. Splicing defects in the ataxia-telangiectasia gene, ATM: Underlying mutations and consequences. Am. J. Hum. Genet. 64(6): 1617–1631.
Verhagen M.M., Last J.I., Hogervorst F.B., Smeets D.F., Roeleveld N., Verheijen F., Catsman-Berrevoets C.E., Wulffraat N.M., Cobben J.M., Hiel J., and Brunt E.R. 2012. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: A genotype–phenotype study. Hum. Mutat. 33(3): 561–571.
Yanofsky R.A., Seshia S.S., Dawson A.J., Stobart K., Greenberg C.R., Booth F.A., Prasad C., Del Bigio M.R., Wrogemann J.J., Fike F., and Gatti R.A. 2009. Ataxia-telangiectasia: Atypical presentation and toxicity of cancer treatment. Can. J. Neurol. Sci. 36(4): 462–467.

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Volume 7Number 2June 2020
Pages: 57 - 60

History

Received: 23 February 2020
Accepted: 18 April 2020
Accepted manuscript online: 4 May 2020

Authors

Affiliations

Ori Scott
Division of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON
Yael Dinur-Schejter
Bone Marrow Transplantation Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Julia Upton
Division of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON
Stephen Feanny [email protected]
Division of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON

Funding Information

This work has not been funded.

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

There are no citations for this item

View Options

View options

PDF

View PDF

Full Text

View Full Text

Get Access

Login options

Check if you access through your login credentials or your institution to get full access on this article.

Subscribe

Click on the button below to subscribe to LymphoSign Journal

Purchase options

Purchase this article to get full access to it.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Media

Other

Tables

Share Options

Share

Share the article link

Share on social media